Thermo Fisher Scientific Dupilumab Polyclonal Antibody

Applications and Tested Dilution

• Application: ELISA
• Tested Dilution: 0.05–1 µg/mL

Product Specifications

Product Specific Information

Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.

Dupilumab (trade name Dupixent) is an FDA-approved drug for the treatment of patients aged 6 years and older with moderate-to-severe atopic dermatitis. It is a human monoclonal antibody that binds to the interleukin-4 receptor alpha (IL-4Rα) subunit shared by the IL-4 and IL-13 receptor complexes, thereby inhibiting IL-4 and IL-13 signaling.
GenScript Anti-Dupilumab Antibody, pAb, Rabbit is produced from the sera of a rabbit immunized with Dupilumab.

Target Information

Dupilumab (Dupixent) is a human monoclonal antibody approved for moderate-to-severe atopic dermatitis in patients aged 6 years and older. It targets the IL-4Rα subunit shared by IL-4 and IL-13 receptor complexes, inhibiting IL-4 and IL-13 signaling.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.